Overview

Update
Total Equity Funding
$101.74M in 3 Rounds from 11 Investors
Most Recent Funding
$60M Venture on June 20, 2016
Headquarters:
Manchester
Description:
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Categories:
Pharmaceutical, Biotechnology, Medical
Website:
http://www.f2g.com

Company Details

Update

F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. The Company was founded on its proprietary genomics technology (MycoBank®) that identifies essential gene targets in fungi. Having received initial funding in 2002 the company then rapidly diversified into chemistry-driven discovery. They have also assembled an experienced development capacity.

Funding Rounds (3) - $101.74M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2016$60M / Venture7
Sep, 2012$30M / Venture6
Aug, 2008£6.3M / Venture4

Current Team (10)

Update

Offices/Locations (1)

Update
  • Office

    PO Box 1, Lankro Way, Eccles

    Manchester, M30 0BH

    GBR

Past Team (1)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos